[Photodynamic therapy: Recommendations for indication and treatment]

Ophthalmologe. 2001 Feb;98(2):216-9; quiz 230. doi: 10.1007/s003470170189.

[Article in German]

Authors

U Schmidt-Erfurth¹, H Laqua

Affiliation

¹ Klinik für Augenheilkunde des Universitätsklinikums Lübeck, Ratzeburger Allee 160, 23538 Lübeck.

PMID: 11263053
DOI: 10.1007/s003470170189

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Age Factors
Aged
Aged, 80 and over
Choroidal Neovascularization / drug therapy*
Choroidal Neovascularization / surgery
Clinical Trials as Topic
Contraindications
Fluorescein Angiography
Follow-Up Studies
Forecasting
Humans
Laser Coagulation*
Macular Degeneration / drug therapy*
Macular Degeneration / surgery
Middle Aged
Myopia / drug therapy*
Ophthalmoscopy
Photochemotherapy* / methods
Photosensitizing Agents / administration & dosage
Photosensitizing Agents / therapeutic use*
Porphyrins / administration & dosage
Porphyrins / therapeutic use*
Prognosis
Recurrence
Time Factors
Verteporfin
Visual Acuity

Substances

Photosensitizing Agents
Porphyrins
Verteporfin